Levetiracetam
Product Images NDC 17856-0685

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 17856-0685). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corps, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

690afec4-figure-01 (Levetiracetam Oral Solution 1)

FDA Label Image

690afec4-figure-02 (Levetiracetam Oral Solution 2)

FDA Label Image

690afec4-figure-03 (Levetiracetam Oral Solution 3)

FDA Label Image

690afec4-figure-04 (Levetiracetam Oral Solution 4)

FDA Label Image

690afec4-figure-05 (Levetiracetam Oral Solution 5)

This text appears to be a table or graph showing two percentages (44.6% and 19.6%) and how they correspond to patients taking a placebo or levetiracetam. However, without additional context, it is not possible to determine what these percentages represent or what condition or study they may relate to.*

FDA Label Image

690afec4-figure-06 (Levetiracetam Oral Solution 6)

FDA Label Image

690afec4-figure-07 (Levetiracetam Oral Solution 7)

FDA Label Image

Label Image (Rspl17856 0685)

This is an oral solution medication of LevETIRACETAM, available only through a prescription. Each 5 mL of the solution contains 500 mg of the medication. The medication is distributed by Atlantic Biologicals and the package is manufactured by Actavis-Mfg. The lot number is given as XXXXXX and the expiration date is 04/17/13. The package is delivered in 5 mL doses and it is packaged by UDOSE LLC located in Miami, FL.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.